Association of vitamin D status with multiple sclerosis in a case-control study from Morocco

被引:13
作者
Skalli, A. [1 ]
Ait Ben Haddou, E. H. [1 ,2 ]
El Jaoudi, R. [3 ]
Razine, R. [4 ]
Mpandzou, G. A. [2 ]
Tibar, H. [1 ,2 ]
El Fahime, E. [5 ]
Bouslam, N. [2 ]
Alami, A. [6 ]
Benomar, A. [1 ,2 ]
Hajjout, K. [6 ]
Yahyaoui, M. [1 ,2 ]
Bouhouche, A. [1 ,2 ]
机构
[1] Univ Mohammed V Rabat, Med Sch & Pharm, Genom Ctr Human Pathol, Res Team Neurol & Neurogenet, Rabat 10100, Morocco
[2] Univ Hosp Rabat Sale, Specialt Hosp, Dept Neurol & Neurogenet, ONO,Rabat Inst, BP 6444, Rabat, Morocco
[3] Mohammed V Univ Rabat, Med Sch & Pharm, Lab Pharmacol & Toxicol, Rabat 10100, Morocco
[4] Mohammed V Univ Rabat, Med Sch & Pharm, Lab Publ Hlth, Rabat 10100, Morocco
[5] Assistance Units Sci & Tech Res, Allal Fassi FAR Corner BP 8027, Rabat 10000, Morocco
[6] Natl Blood Transfus Ctr, 472 Mfadel Cherkaoui St, Rabat, Morocco
关键词
Case-control study; Moroccan cohort; Multiple sclerosis; Serum 25(OH) vitamin D3; Disease severity; D DEFICIENCY; 25-HYDROXYVITAMIN-D LEVELS; SERUM; 25-HYDROXYVITAMIN-D; ULTRAVIOLET-RADIATION; RISK; DISABILITY; ENCEPHALOMYELITIS; EPIDEMIOLOGY; POPULATION; PREVALENCE;
D O I
10.1016/j.neurol.2017.06.030
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background. - Growing evidence suggests that hypovitaminosis D contributes to the pathogenesis of multiple sclerosis (MS). Objective. - This study aimed to evaluate whether vitamin D levels are associated with having MS and some of its characteristics in the Moroccan population. Methods. -Using liquid chromatography-tandem mass spectrometry, the 25(OH) D-3 metabolite was measured to quantify vitamin D serum levels (DSLs) in 113 patients with MS and 146 healthy controls matched for gender and age. DSLs were then compared between patients and controls, with correlations sought between DSLs and gender, age at onset, disease duration, MS type, degree of disability (EDSS score) and disease severity (MSSS) in patients. Results. - Hypovitaminosis D (DSL < 30 ng/mL) was observed in 97.3% of MS patients and in 98.6% of controls. Although the mean DSL was slightly lower in patients (11.69 +/- 6.97 ng/mL) than in controls (12.98 +/- 6.58 ng/mL), there was no significant association between DSL and MS status (P = 0.131). Similarly, among patients, no apparent association was found between DSL and MS type (P = 0.214), EDSS score (P = 0.076) or MSSS (P = 0.772). Conclusion. - Our study suggests that DSL is not associated with having MS nor with MS type, degree of disability or disease severity in the Moroccan population. On the other hand, DSL was lower in women and decreased with age. (C) 2018 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:150 / 156
页数:7
相关论文
共 51 条
[1]   Sunlight is associated with decreased multiple sclerosis risk: no interaction with human leukocyte antigen-DRB1*15 [J].
Baarnhielm, M. ;
Hedstrom, A. K. ;
Kockum, I. ;
Sundqvist, E. ;
Gustafsson, S. A. ;
Hillert, J. ;
Olsson, T. ;
Alfredsson, L. .
EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 (07) :955-962
[2]   Assessment of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D3 concentrations in male and female multiple sclerosis patients and control volunteers [J].
Barnes, M. S. ;
Bonham, M. P. ;
Robson, P. J. ;
Strain, J. J. ;
Lowe-Strong, A. S. ;
Eaton-Evans, J. ;
Ginty, F. ;
Wallace, J. M. W. .
MULTIPLE SCLEROSIS, 2007, 13 (05) :670-672
[3]   Frequency and clinical patterns of multiple sclerosis in Arab countries: A systematic review [J].
Benamer, Hani T. S. ;
Ahmed, Elfatih S. M. ;
Al-Din, Amir S. ;
Grosset, Donald G. .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 278 (1-2) :1-4
[4]   Gender Differences in 1,25 Dihydroxyvitamin D3 Immunomodulatory Effects in Multiple Sclerosis Patients and Healthy Subjects [J].
Correale, Jorge ;
Ysrraelit, Maria C. ;
Gaitan, Maria I. .
JOURNAL OF IMMUNOLOGY, 2010, 185 (08) :4948-4958
[5]   Immunomodulatory effects of Vitamin D in multiple sclerosis [J].
Correale, Jorge ;
Celica Ysrraelit, Mara ;
Ines Gaitan, Maria .
BRAIN, 2009, 132 :1146-1160
[6]   More severe disability of North Africans vs Europeans with multiple sclerosis in France [J].
Debouverie, M. ;
Lebrun, C. ;
Jeannin, S. ;
Pittion-Vouyovitch, S. ;
Roederer, T. ;
Vespignani, H. .
NEUROLOGY, 2007, 68 (01) :29-32
[7]   Can we prevent or treat multiple sclerosis by individualised vitamin D supply? [J].
Jan Dörr ;
Andrea Döring ;
Friedemann Paul .
EPMA Journal, 2013, 4 (1)
[8]   Melanocortin 1 receptor genotype, past environmental sun exposure, and risk of multiple sclerosis [J].
Dwyer, T. ;
van der Mei, I. ;
Ponsonby, A. -L. ;
Taylor, B. V. ;
Stankovich, J. ;
McKay, J. D. ;
Thomson, R. J. ;
Polanowski, A. M. ;
Dickinson, J. L. .
NEUROLOGY, 2008, 71 (08) :583-589
[9]   Vitamin D in African Americans with multiple sclerosis [J].
Gelfand, J. M. ;
Cree, B. A. C. ;
McElroy, J. ;
Oksenberg, J. ;
Green, R. ;
Mowry, E. M. ;
Miller, J. W. ;
Hauser, S. L. ;
Green, A. J. .
NEUROLOGY, 2011, 76 (21) :1824-1830
[10]   Differences between blood donors and a population sample: implications for case-control studies [J].
Golding, Jean ;
Northstone, Kate ;
Miller, Laura L. ;
Smith, George Davey ;
Pembrey, Marcus .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2013, 42 (04) :1145-1156